Anila Duni
Overview
Explore the profile of Anila Duni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Papasotiriou M, Stangou M, Chlorogiannis D, Marinaki S, Xydakis D, Sampani E, et al.
Front Med (Lausanne)
. 2022 Mar;
9:778464.
PMID: 35242773
Background: Immunoglobulin A nephropathy (IgAN) is among the commonest glomerulonephritides in Greece and an important cause of end-stage kidney disease (ESKD) with an insidious chronic course. Thus, the recently published...
12.
Bolignano D, Dounousi E, Presta P, Greco M, Duni A, Crugliano G, et al.
Clin Kidney J
. 2022 Mar;
15(2):303-310.
PMID: 35233284
Background: Iron deficiency is highly prevalent among patients undergoing chronic haemodialysis (HD) but its correct identification is often problematic as common biomarkers of iron status, such as transferrin saturation (TSAT)...
13.
Duni A, Markopoulos G, Mallioras I, Pappas H, Pappas E, Koutlas V, et al.
Front Immunol
. 2021 Dec;
12:760249.
PMID: 34925330
Background: The humoral and cellular immune responses to SARS-COV-2 vaccination remain to be elucidated in hemodialysis (HD) patients and kidney transplant recipients (KTRs), considering their baseline immunosuppressed status. The aim...
14.
Duni A, Vartholomatos G, Balafa O, Ikonomou M, Tseke P, Lakkas L, et al.
Front Med (Lausanne)
. 2021 Nov;
8:724316.
PMID: 34746172
The altered expression of immune cells including monocyte subsets, natural killer (NK) cells and CD4+CD25+ regulatory T cells (Tregs) in end-stage kidney disease, affect the modulation of inflammation and immunity...
15.
Duni A, Koutlas V, Tsitouridis A, Tzalavra E, Oikonomaki T, Kitsos A, et al.
Transplant Proc
. 2021 Oct;
53(9):2786-2792.
PMID: 34690001
Background: Kidney transplantation is complicated by various electrolyte disturbances with variable reported prevalence and incidence and of multifactorial pathogenesis. The aim of our study was the retrospective longitudinal assessment of...
16.
Balafa O, Duni A, Tseke P, Rapsomanikis K, Pavlakou P, Ikonomou M, et al.
J Clin Med
. 2021 Aug;
10(16).
PMID: 34441945
Background: Longitudinal surveillance of peritoneal membrane function is crucial in defining patients with a risk of ultrafiltration failure. Long PD is associated with increased low molecular weight solute transport and...
17.
Dounousi E, Tellis C, Pavlakou P, Duni A, Liakopoulos V, Mark P, et al.
Oxid Med Cell Longev
. 2021 Aug;
2021:6677012.
PMID: 34336112
Proprotein convertase subtilisin/kexin 9 (PCSK9) plays an important role in lipid metabolism while available literature regarding its involvement in the pathogenesis of atherosclerosis and in the expression of genes associated...
18.
Duni A, Kitsos A, Liapis G, Tatsis V, Pappas C, Dounousi E
Kidney Int Rep
. 2021 May;
6(5):1459-1463.
PMID: 34013126
No abstract available.
19.
Duni A, Liakopoulos V, Koutlas V, Pappas C, Mitsis M, Dounousi E
Int J Mol Sci
. 2021 Mar;
22(4).
PMID: 33671524
The damage of the endothelial glycocalyx as a consequence of ischemia and/or reperfusion injury (IRI) following kidney transplantation has come at the spotlight of research due to potential associations with...
20.
Oikonomaki D, Dounousi E, Duni A, Roumeliotis S, Liakopoulos V
Diabetes Res Clin Pract
. 2020 Dec;
172:108604.
PMID: 33338553
Aims: We aimed to conduct a systematic review and meta-analysis regarding the use of incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists as well as...